Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.
Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE
Breast Cancer Res 2009, 11:R11
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research    
Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response
Bhuvaneswari R, Gan YY, Soo KC, Olivo M
Molecular Cancer 2009, 8:94 (2 November 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.